Essential Knowledge Briefing: Women's Health
Women's Health is an up-to-date review to understand the broad perspectives of applications of OCPs and provide an understanding of the gradual transition of menopause, a critical phase of a...
Selektive Interleukin-23-Inhibition mit Guselkumab
Nachdem Guselkumab (TREMFYA®) für die Behandlung von Erwachsenen mit mittelschwerer bis schwerer Plaque-Psoriasis, die für eine systemische Therapie infrage kommen, bereits seit November 2017...
Keeping an eye on patient privacy
One of our ophthalmologist Members recently contacted us about an unusual request from the police to breach patient confidentiality and privacy....
Sn-2 palmitate enriched infant formula is associated with increased bone mineral content and calcium bioavailability
Recent evidence suggests that in addition to softer stools, bone mineral content at four months may be increased in infants fed sn-2 palmitate enriched formula. The Béghin (et al) study helps us...
ECCO 2021 Highlights: Interdisciplinary Roundtable
Following ECCO 2021, Stefan Schreiber, MD, Ph.D., Prof. Dr. Rieke Alten, and president of ECCO Laurent Peyrin-Biroulet, MD, Ph.D. discussed the latest developments and findings in Gastroenterology...
To see is to believe? Guidance on using imaging to optimise patient care in psoriatic arthritis
The IL-23 pathway, its role in (early) psoriatic arthritis, and the use of imaging techniques to support the diagnosis and management of the disease, were discussed in a Janssen-sponsored satellite...
EULAR 2021 Highlights: Interdisciplinary Roundtable
Following EULAR 2021, Prof. Dr. med Gerd Burmester and Prof. Dr. Sebastian Zeissig discussed the latest developments and findings in rheumatology and gastroenterology, and review highlights of the...
Alpelisib in the treatment of breast cancer: overall survival and sequencing
PIK3CA mutations are present in approximately 40% of HR+ tumours.1 In clinical trials in women with HR+/HER2– advanced breast cancer, the frequency of PIK3CA mutations was 33–43%.2–4 SOLAR-1, a...
Alpelisib in the treatment of breast cancer: managing adverse events
Advances in management have greatly improved outcomes for women with early breast cancer and drug treatment has replaced surgery as the primary treatment option for many patients.1 Advanced breast...
A New Era In Atopic Dermatitis Treatment: Translation of Type 2 Inflammatory Disease Mechanisms Into Novel Systemic Therapies
...